Experience with external review panels to validate a large clinical pharmacy intervention study

Canadian Journal of Hospital Pharmacy

Volumn 51, Issue 5, 1998, Pages 200-208

  McLean, William ^a   Poston, Jeffrey ^b   Tsao, Stephanie ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Canadian Pharmaceutical Association   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG COST; HOSPITAL PHARMACY; PATIENT MONITORING; PHARMACIST; PHYSICIAN; RISK BENEFIT ANALYSIS;

EID: 0031737763     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Strong DK, Tsang GWY. Focus and impact of pharmacists interventions. Can J Hosp Pharm 1993:46:101-8.
2. Keys PW, South JC, Duffy SMG. Quality of care evaluation applied to assessment of clinical pharmacy services. Am J Hosp Pharm 1975;32:897-902.
3. Brown G. Assessing the clinical impact of pharmacists' interventions. Am J Hosp Pharm 1991;48:2644-6.
4. Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm 1988;22:252-9.
5. Bjornson DC, Hiner WO Jr, Potyk RP, Nelson BA, Lombardo FA, Morton TA et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993;50:1875-84.
6. A White Paper on the Establishment and Elaboration of Clinical Pharmacy Service in Hospitals. Ottawa, 1990, Canadian Society of Hospital Pharmacists.
7. Ogle BG, McLean WM, Poston JW. The Clinical Pharmacy Services Study. Can J Hosp Pharm 1996;49(suppl):S5-S25.
8. Bayliff CD. The CPSS/L=Étude sur les services de pharmacie clinique. (Editorial) Can J Hosp Pharm 1994;47:145-6
9. Jones J, Hunter D. Consensus methods for medical and health services research. Brit Med J 1995;311:376-80.
10. McKee M, Priest P, Ginzler M, Black N. How representative are members of expert panels? Qual Assur Health Care 1991;3:89-94.
11. Scott EA, Black NA. Appropriateness of cholecystectomy - a consensus panel approach. Gut 1991;9:1066-70.
12. Leape LL, Park RE, Kahan JP, Brook RH. Group judgments of appropriateness: the effect of panel composition. Qual Assur Health Care 1992;4:151-9.
13. Herrin J, Etchason JA, Kahan JP, Brook RH, Ballard DJ. Effect of panel composition on physician ratings of appropriateness of abdominal aortic aneurysm surgery. Health Policy 1997; 42:67-81.
14. Oddone EZ, Samsa G, Matchar DB. Global judgments versus decision-model-facilitated judgments: are experts internally consistent? Med Decis Making 1994;14:19-26.
15. Streiner DL, Norman GR. Health Measurement Scales. New York: Oxford University Press, 1989.
16. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. Brit Med J 1992;304:1491-4
17. Bayliff CD, Einarson TR. Physician assessment of pharmacists= intervention - A model of estimating cost avoidance and determining quality assurance. Can J Hosp Pharm 1990;4:167-71,195.
18. Ilersich AL, Rovers JP, Einarson TR. A pilot study of process and outcome assessment in antibiotic therapy. Can J Hosp Pharm 1991;5:251-8,270.
19. Hastings GE, Sonneborn R, Lee GH, Vick L, Sasmor L. Peer review checklist: reproducibility and validity of a method for evaluating the quality of ambulatory care. Am J Public Health 1980;70:222-8.
20. Hatoum HT, Hutchinson RA, Elliott LR, Kendzierski DL. Physicians' review of significant interventions by clinical pharmacists in patient care. Drug Intell Clin Pharm 1988;22:980-2.
21. Goldman RL. The reliability of peer assessments of quality of care. J Am Med Assoc 1992;267:958-60.
22. Sulick JA, Pathak DS. The perceived influence of clinical pharmacy services on physician prescribing behaviour: A matched-pair comparison of pharmacists and physicians. Pharmacotherapy 1996;16:1133-41.